Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...

Revolutionizing Egyptian oil exploration

TAG Oil’s Tech-Driven Breakthrough In the vast expanse of Egypt’s Western Desert, a hidden treasure of oil and gas resources lies in wait, largely untapped until now. The Badr oil field (BED-1) in the Western Desert holds the promisi...

Buzz on the Bullboards: Markets underperforming, or is the best yet to come?

So, the “September rally” didn’t really pan out as many indices hit lows not seen in months, but at least interest rates were kept firm for now, so that is some good news, right? Investors have been worried about the possibility o...

Buzz on the Bullboards: Emphasis on the BULL

In the past week, the U.S. stock market hit a turning point and the S&P 500 has been on a real climb, reaching the 4,300 benchmark for the first time since August 2022. Its rally ended the bear market that began in January of last year, achieving 20 per cent growth since ...

Buzz on the Bullboards: Sell in May and go away?

As investors assess the strategy of liquidating positions before the summer, lingering concerns over an impending economic recession haven’t appeared to slow down activity on the Bullboards. Instead, as we approach zero hour on the deadline to settle t...

Buzz on the Bullboards: Raise the roof?

Weakness in commodities’ prices have been felt on Bay Street and Wall Street as traders took stock of consumer inflation data. U.S. inflation fell faster than expected in last month to 4.9 per cent, raising chances of a pause in Federal Reserve rate hi...

Meet the plant-based food company that’s set for success

Welcome to the Market Herald Video Q&A Podcast. I’m Brieanna McCutcheon. Most people, if not everyone, know someone vegan, vegetarian, or flexitarian. This is good news for companies like Naturally Splendid, which aim to provide tasty and delicious...

A Petroleum Co. That’s Poised & Positioned to Help Fill the Global Energy Void

The Russian invasion of Ukraine has shone a bright light on the need for the west – particularly Europe – to find alternative sources of energy and to break its dependence on Russian oil and natural gas. That’s where companies like ShaMaran Petroleum C...

Buzz on the Bullboards: Who is the Latest Hot Play?

(Image via BlackBerry Limited.) From short-term healthcare plays, long-term technology bets, to uncertain cannabis swings … small-cap investors have had their hands full keeping up with the markets over the past few months. We’ve noted that each...
1 2 3 4 5 6 7 8 9 10 ...